Truist Securities Adjusts Price Target on ICON to $284 From $295, Keeps Buy Rating
Icon (ICLR) Receives a Buy From Truist Financial
Nephron Upgrades ICON to Buy, Price Target Is $280
Icon Is Maintained at Neutral by Baird
Icon Price Target Cut to $255.00/Share From $270.00 by Leerink Partners
J.P. Morgan Keeps Their Buy Rating on Icon (ICLR)
Icon Price Target Cut to $285.00/Share From $369.00 by TD Cowen
UBS Adjusts Price Target on ICON to $290 From $380, Maintains Buy Rating
Icon Is Maintained at Outperform by Leerink Partners
Jefferies Sticks to Their Buy Rating for Icon (ICLR)
Icon Price Target Cut to $249.00/Share From $340.00 by Baird
Buy Rating for Icon (ICLR) Despite Q3:24 Challenges, Driven by Strategic Partnerships and Solid Fundamentals
Icon Price Target Announced at $340.00/Share by Baird
Icon Cut to Neutral From Outperform by Baird
Baird Downgrades ICON to Neutral From Outperform, Price Target Is $340
Barclays Reaffirms Their Buy Rating on Icon (ICLR)
Deutsche Bank Adjusts ICON Price Target to $360 From $370, Maintains Buy Rating
Icon (ICLR) Receives a Buy From J.P. Morgan
Icon Price Target Announced at $311.00/Share by Redburn Atlantic
Icon Initiated at Neutral by Redburn Atlantic